Affording women who are vaccinated up to 20 to 25 years of protection, GSK’s cervical cancer vaccine is also effective against persistent infections caused by 12 other cancer-causing HPV strains aside from HPV 16 and 18. Females 10 years of age and older can benefit from the vaccine as it is designed for both young and adult women.